DE60001687T2 - Trovafloxacin enhaltende Suspensionen zur oralen Anwendung - Google Patents
Trovafloxacin enhaltende Suspensionen zur oralen AnwendungInfo
- Publication number
- DE60001687T2 DE60001687T2 DE60001687T DE60001687T DE60001687T2 DE 60001687 T2 DE60001687 T2 DE 60001687T2 DE 60001687 T DE60001687 T DE 60001687T DE 60001687 T DE60001687 T DE 60001687T DE 60001687 T2 DE60001687 T2 DE 60001687T2
- Authority
- DE
- Germany
- Prior art keywords
- trovafloxacin
- crystals
- oral use
- suspensions containing
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13746399P | 1999-06-04 | 1999-06-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60001687D1 DE60001687D1 (de) | 2003-04-24 |
DE60001687T2 true DE60001687T2 (de) | 2003-12-18 |
Family
ID=22477550
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60001687T Expired - Fee Related DE60001687T2 (de) | 1999-06-04 | 2000-05-30 | Trovafloxacin enhaltende Suspensionen zur oralen Anwendung |
Country Status (10)
Country | Link |
---|---|
US (1) | US6239141B1 (de) |
EP (1) | EP1057828B1 (de) |
JP (1) | JP3465820B2 (de) |
AT (1) | ATE234835T1 (de) |
BR (1) | BR0002577A (de) |
CA (1) | CA2311112A1 (de) |
DE (1) | DE60001687T2 (de) |
DK (1) | DK1057828T3 (de) |
ES (1) | ES2194677T3 (de) |
PT (1) | PT1057828E (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE285821T1 (de) * | 1999-10-08 | 2005-01-15 | Affinium Pharm Inc | Fab i inhibitoren |
BR0207930A (pt) * | 2001-03-05 | 2004-03-02 | Ortho Mcneil Pharm Inc | Composições farmacêuticas lìquidas com sabor mascarado |
CA2444597A1 (en) * | 2001-04-06 | 2002-10-06 | Affinium Pharmaceuticals, Inc. | Fab i inhibitors |
US20030068829A1 (en) * | 2001-06-25 | 2003-04-10 | Symyx Technologies, Inc. | High throughput crystallographic screening of materials |
MXPA04000294A (es) * | 2001-07-10 | 2004-05-04 | Pharmacia & Upjhon Company | Tiacin oxazolidinonas cristalinas. |
UA76483C2 (en) | 2001-08-15 | 2006-08-15 | Upjohn Co | Crystalline form of malic acid salt of n-|2-(diethylamino)ethyl|-5-|(5-fluoro -2--oxo-3n-indol-3-ylidene)methyl]-2,4- dimelhyl-1n-pyrrole-3-carboxamide (variants), a method for preparing and compositions thereof |
JP4619658B2 (ja) * | 2002-03-12 | 2011-01-26 | 富山化学工業株式会社 | 快い味の経口懸濁液および方法 |
US8367098B2 (en) * | 2002-04-30 | 2013-02-05 | The Population Council, Inc. | Unique combinations of antimicrobial compositions |
AU2003245252A1 (en) * | 2002-04-30 | 2003-11-17 | Fmc Corporation | Carrageenan based antimicrobial compositions |
JP4859460B2 (ja) | 2002-12-06 | 2012-01-25 | アフィニウム ファーマシューティカルズ, インク. | ヘテロ環化合物、その製造方法および治療におけるその使用 |
ATE409485T1 (de) | 2003-03-17 | 2008-10-15 | Affinium Pharm Inc | Pharmazeutische zusammensetzungen inhibitoren von fab i und weitere antibiotika enthaltend |
US20050031700A1 (en) * | 2003-07-18 | 2005-02-10 | Sanatarus, Inc. | Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders |
KR101299399B1 (ko) * | 2004-06-04 | 2013-08-22 | 아피늄 파마슈티컬스, 인크. | 치료제, 및 그의 제조 및 사용 방법 |
JP2009518399A (ja) * | 2005-12-05 | 2009-05-07 | アフィニウム ファーマシューティカルズ, インク. | Fabi阻害剤および抗菌剤としてのヘテロ環アクリルアミド化合物 |
EP2687533B1 (de) | 2006-07-20 | 2017-07-19 | Debiopharm International SA | Acrylamidderivate als FAB-I-Hemmer |
EP3255045A1 (de) | 2007-02-16 | 2017-12-13 | Debiopharm International SA | Salze, prodrugs und polymorphe von fab i-inhibitoren |
JP6085026B2 (ja) | 2012-06-19 | 2017-02-22 | デビオファーム インターナショナル エスエーDebiopharm International Sa | (e)−n−メチル−n−((3−メチルベンゾフラン−2−イル)メチル)−3−(7−オキソ−5,6,7,8−テトラヒドロ−1,8−ナフチリジン−3−イル)アクリルアミドのプロドラッグ誘導体 |
CA3014541A1 (en) | 2016-02-26 | 2017-08-31 | Debiopharm International S.A. | Medicament for treatment of diabetic foot infections |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5164402A (en) | 1989-08-16 | 1992-11-17 | Pfizer Inc | Azabicyclo quinolone and naphthyridinone carboxylic acids |
US5266559A (en) | 1989-10-27 | 1993-11-30 | Firmenich S.A. | Use of unsaturated macrocyclic lactones as perfuming ingredients |
US5391763A (en) | 1990-07-11 | 1995-02-21 | Pfizer Inc. | 3-aza-bicyclo[3.1.0]hexanes which are intermediates for anti-bacterial azabicyclo quinolone carboxylic acids |
TW271400B (de) | 1992-07-30 | 1996-03-01 | Pfizer | |
US5763454A (en) | 1995-06-06 | 1998-06-09 | Pfizer, Inc. | Crystal form of anhydrous 7-( 1α,5α,6α!-6-amino-3-azabicyclo 3.1.0!hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid, methanessulfonic acid salt |
AU704115B2 (en) | 1995-08-29 | 1999-04-15 | Pfizer Inc. | Zwitterionic forms of trovafloxacin |
RU2151152C1 (ru) * | 1995-08-29 | 2000-06-20 | Пфайзер Инк. | Полиморфы 6-n-(l-ala-l-ala)-тровафлоксацина |
US6114531A (en) * | 1998-07-28 | 2000-09-05 | Pfizer Inc. | Process for preparing quinolone and naphthyridone carboxylic acids |
-
2000
- 2000-05-05 US US09/565,420 patent/US6239141B1/en not_active Expired - Fee Related
- 2000-05-16 JP JP2000142971A patent/JP3465820B2/ja not_active Expired - Fee Related
- 2000-05-30 DE DE60001687T patent/DE60001687T2/de not_active Expired - Fee Related
- 2000-05-30 AT AT00304550T patent/ATE234835T1/de not_active IP Right Cessation
- 2000-05-30 PT PT00304550T patent/PT1057828E/pt unknown
- 2000-05-30 DK DK00304550T patent/DK1057828T3/da active
- 2000-05-30 ES ES00304550T patent/ES2194677T3/es not_active Expired - Lifetime
- 2000-05-30 EP EP00304550A patent/EP1057828B1/de not_active Expired - Lifetime
- 2000-06-02 CA CA002311112A patent/CA2311112A1/en not_active Abandoned
- 2000-06-05 BR BR0002577-1A patent/BR0002577A/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2311112A1 (en) | 2000-12-04 |
BR0002577A (pt) | 2001-01-02 |
EP1057828B1 (de) | 2003-03-19 |
DE60001687D1 (de) | 2003-04-24 |
EP1057828A3 (de) | 2001-05-16 |
JP2000344770A (ja) | 2000-12-12 |
ES2194677T3 (es) | 2003-12-01 |
PT1057828E (pt) | 2003-07-31 |
ATE234835T1 (de) | 2003-04-15 |
DK1057828T3 (da) | 2003-07-14 |
EP1057828A2 (de) | 2000-12-06 |
JP3465820B2 (ja) | 2003-11-10 |
US6239141B1 (en) | 2001-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60001687D1 (de) | Trovafloxacin enhaltende Suspensionen zur oralen Anwendung | |
TWI232219B (en) | Compounds containing cyclohexane group, process for preparing them and pharmaceutical composition containing them | |
MY123354A (en) | 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives | |
MY136520A (en) | Novel compounds | |
NO20093464L (no) | Nye medikamentblandinger basert pa anti-cholinergisk effektive forbindelser og beta-mimetika | |
DE60321929D1 (de) | Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen | |
IL165715A0 (en) | 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof | |
UA70298A (uk) | Похідні с-4"-заміщених макролідів, спосіб їх одержання, проміжні сполуки, фармацевтична композиція та спосіб лікування бактеріальної інфекції або протозойної інфекції | |
ATE249422T1 (de) | Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe | |
CA2366932A1 (en) | Cyclic protein tyrosine kinase inhibitors | |
BG101118A (en) | Therapeutical compounds | |
ATE457027T1 (de) | Substituierte 1,4,8-triazaspiroä4.5 decan-2-on- verbindungen zur behandlung von fettsucht | |
EE05091B1 (et) | Oligosahhariidid, nende valmistamismeetod ja kasutamine ning farmatseutilised kompositsioonid | |
ATE350377T1 (de) | Substituierte 3-pyrrolidin-indol-derivate | |
AP2001002142A0 (en) | 13-membered azalides and their use as antibiotic agents. | |
EE200000587A (et) | Uued 15-lülilised ketoasaliidid, meetod nende valmistamiseks ning neid sisaldav farmatseutiline kompositsioon kasutamiseks bakternakkuste ravis | |
DE59813162D1 (de) | Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen | |
IL160171A0 (en) | Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
SE9902765D0 (sv) | Novel compounds | |
ATE268337T1 (de) | C11-carbamate von antibakteriellen makroliden | |
ATE369348T1 (de) | Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie | |
HK1065305A1 (en) | Substituted 4-aminocyclohexanol derivatives | |
BRPI0410026A (pt) | derivados de 3-amino-croman quinolina | |
HUP9904578A2 (hu) | Xanomelin alkalmazása bipoláris depresszió kezelésére szolgáló gyógyszerkészítmények előállítására | |
SE9803158D0 (sv) | A new composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |